Hjem › Endometriekreft › North Carolina › Durham
Kliniske studier for Endometriekreft i Durham, NC
16 studier for Endometriekreft søker deltakere på steder i og rundt Durham (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
RekruttererFase 3
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi unna
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RekruttererFase 2
- Duke University Medical Center, Durham
A Study of PHST001 in Advanced Solid Tumors
RekruttererFase 1
- Duke Cancer Institute, Durham
Tirzepatide in Obesity-Driven Endometrial Cancer
RekruttererTidlig fase 1
- Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi unna
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RekruttererFase 1/2
- Duke University, Durham
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
RekruttererFase 2
- Duke University Medical Center, Durham
DESTINY-PANTUMOUR04
RekruttererObservasjonsstudie
- Research Site, Durham
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
RekruttererFase 2
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi unna
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
RekruttererFase 3
- Duke Cancer Institute ( Site 6049), Durham
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
RekruttererObservasjonsstudie
- UNC- Chapel Hill, Chapel Hill · 10 mi unna
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
RekruttererFase 3
- Duke Cancer Institute, Durham
A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors
RekruttererFase 1
- Duke Cancer Institute, Durham
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RekruttererFase 1/2
- Duke University, Durham
ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer
RekruttererFase 1
- Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi unna
Multimedia Aid for Genetic Testing in Gynecologic Oncology
Rekrutterer
- Univeristy of North Carolina at Chapel Hill, Chapel Hill · 10 mi unna
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Chapel Hill · 10 mi unna
Endometriekreft-studier i andre byer
- Houston, TX68 studier
- New York City, NY52 studier
- Boston, MA50 studier
- Arlington, VA39 studier
- Nashville, TN38 studier
- Los Angeles, CA34 studier
- St. Louis, MO29 studier
- Philadelphia, PA28 studier
- San Antonio, TX27 studier
- Columbus, OH25 studier
- Oklahoma City, OK25 studier
- Chicago, IL25 studier
Andre studier i Durham
- Brystkreft64 studier
- Kreft (alle typer)58 studier
- Ikke-småcellet lungekreft39 studier
- Multipelt myelom37 studier
- Akut myelogen leukemi33 studier
- Metastatisk kreft33 studier
- Prostatakreft32 studier
- Lungekreft32 studier
- Kolorektal kreft28 studier
- Eggstokkreft27 studier
- Kronisk lymfatisk leukemi27 studier
- Hjertesvikt26 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.